There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Zynex (ZYXI – Research Report) and Privia Health Group (PRVA – Research Report) with bullish sentiments.
Zynex (ZYXI)
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Zynex on January 11 and set a price target of $13.00. The company’s shares closed last Friday at $10.11.
According to TipRanks.com, Chadha is a 1-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Zynex with a $16.50 average price target.
See the top stocks recommended by analysts >>
Privia Health Group (PRVA)
RBC Capital analyst Sean Dodge maintained a Buy rating on Privia Health Group on January 11 and set a price target of $32.00. The company’s shares closed last Friday at $21.25, close to its 52-week low of $19.68.
According to TipRanks.com, Dodge has 0 stars on 0-5 stars ranking scale with an average return of
Privia Health Group has an analyst consensus of Strong Buy, with a price target consensus of $32.00, implying a 45.1% upside from current levels. In a report issued on January 4, Truist Financial also maintained a Buy rating on the stock with a $32.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ZYXI:
